Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Shu

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Scientific Reports|July 4, 2015
Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNADaxiang Cui, Chunlei Zhang, Bing Liu, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 22, 2023
Fluorescence-Amplified Origami Microneedle Device for Quantitatively Monitoring Blood GlucoseXianlei Li, Xuehui Xu, Kewei Wang, et al.
The Lancet Regional Health. Western Pacific|July 24, 2023
Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trialFuxiang Wang, Wen Xiao, Yimin Tang, et al.
Oncotarget|April 18, 2015
RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse modelTae Jin Lee, Farzin Haque, Dan Shu, et al.
Frontiers in Medicine|January 31, 2022
Pulmonary Sequelae in Patients After Recovery From Coronavirus Disease 2019: A Follow-Up Study With Chest CTXuejiao Liao, Dapeng Li, Zhi Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2017
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21Tae Jin Lee, Ji Young Yoo, Dan Shu, et al.
Cancer Letters|August 8, 2024
Platelets promote primary hepatocellular carcinoma metastasis through TGF-β1-mediated cancer cell autophagyMeng Lu, Xue Gong, Yu-Min Zhang, et al.
Engineering (Beijing, China)|April 30, 2020
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control StudyQingxian Cai, Minghui Yang, Dongjing Liu, et al.
Med (New York, N.Y.)|January 5, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Scientific Reports|July 4, 2015
Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNADaxiang Cui, Chunlei Zhang, Bing Liu, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 22, 2023
Fluorescence-Amplified Origami Microneedle Device for Quantitatively Monitoring Blood GlucoseXianlei Li, Xuehui Xu, Kewei Wang, et al.
The Lancet Regional Health. Western Pacific|July 24, 2023
Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trialFuxiang Wang, Wen Xiao, Yimin Tang, et al.
Oncotarget|April 18, 2015
RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse modelTae Jin Lee, Farzin Haque, Dan Shu, et al.
Frontiers in Medicine|January 31, 2022
Pulmonary Sequelae in Patients After Recovery From Coronavirus Disease 2019: A Follow-Up Study With Chest CTXuejiao Liao, Dapeng Li, Zhi Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2017
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21Tae Jin Lee, Ji Young Yoo, Dan Shu, et al.
Cancer Letters|August 8, 2024
Platelets promote primary hepatocellular carcinoma metastasis through TGF-β1-mediated cancer cell autophagyMeng Lu, Xue Gong, Yu-Min Zhang, et al.
Engineering (Beijing, China)|April 30, 2020
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control StudyQingxian Cai, Minghui Yang, Dongjing Liu, et al.
Med (New York, N.Y.)|January 5, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Pageof 15